Bottom line
TCV vs MEIKX: the short answer
TCV (Towle Value ETF) and MEIKX (MFS Value Fund) are both etfs.
MEIKX is cheaper at 0.44% vs 0.85% — a difference of $41 a year per $10,000 invested.
Over five years, MEIKX returned +8.3% a year vs +6.3% for TCV (reporting dates differ).
Updated Nov 19, 2026
TCV vs MEIKX side by side
| TCV | MEIKX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ARK Invest | MFS |
| Category | Large Value | Large Value |
| Expense ratio | 0.85% | 0.44% |
| Annual cost per $10k | $85 | $44 |
| 10-yr cost on $10k (prospectus) | $1,049 | $566 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +1.5% | +12.0% |
| 5-yr return (annualized) | +6.3% | +8.3% |
| 10-yr return (annualized) | +7.8% | +8.9% |
| Best quarter | +39.7% | — |
| Worst quarter | −49.2% | — |
| Net assets (fund) | $202.1M | $51.1B |
| Number of holdings | 42 | 71 |
| Portfolio turnover | 89% | 1% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
TCV and MEIKX share none of their top holdings.
TCV top 10
- Oscar Health Inc — 3.62%
- TD SYNNEX Corp — 3.46%
- BorgWarner Inc — 3.39%
- Arrow Electronics Inc — 3.34%
- United Natural Foods Inc — 3.32%
- Cleveland-Cliffs Inc — 3.27%
- Magna International Inc — 2.88%
- ArcBest Corp — 2.79%
- Molina Healthcare Inc — 2.79%
- Lear Corp — 2.78%
MEIKX top 10
- JPMorgan Chase & Co — 4.28%
- Cigna Group/The — 2.80%
- Johnson & Johnson — 2.75%
- Analog Devices Inc — 2.71%
- Morgan Stanley — 2.68%
- RTX Corp — 2.50%
- KLA Corp — 2.47%
- Progressive Corp/The — 2.45%
- Boeing Co/The — 2.42%
- Exxon Mobil Corp — 2.33%
FAQ
What is the difference between TCV and MEIKX?
TCV (Towle Value ETF) and MEIKX (MFS Value Fund) are both etfs. MEIKX is cheaper at 0.44% vs 0.85% — a difference of $41 a year per $10,000 invested.
Which is cheaper, TCV or MEIKX?
MEIKX has the lower expense ratio (0.44%).
Should I own both TCV and MEIKX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.